Journal of medical Internet research · 2026
Development and Preliminary Validation of ORCA-PD, an Online Rapid Cognitive Assessment for Parkinson Disease: Mixed Methods Study.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lithwick Algon Avigail, Brisman Sarah, Lin Chi-Ying R, Saban William
Аннотация
BACKGROUND: Traditional in-person neuropsychological tests for Parkinson disease (PD) lack accessibility, scalability, and PD specificity. Mobility impairments hinder access to in-person assessments, and long waiting times for expert evaluation limit scalability. Common tools for cognitive screening, such as the Montreal Cognitive Assessment, are generic and not specific to PD.
OBJECTIVE: The goal of this study was to address these challenges by leveraging the internet. This study aimed to develop a sensitive tool to detect cognitive impairments in early- to mid-stage PD in an accessible and scalable manner.
METHODS: We developed the Online Rapid Cognitive Assessment for Parkinson's Disease (ORCA-PD), a brief (~15 min), fully self-administered tool, tailored to detect PD-specific impairments remotely. In a cross-sectional study, 112 participants from diverse geographical locations completed the ORCA-PD and a usability questionnaire. Task selection for ORCA-PD was guided by meta-analyses and comprehensive reviews, which demonstrated medium-to-high sensitivity to PD compared to healthy controls.
RESULTS: Participants from more than 30 geographical locations showed a 93% (135/145) completion rate, with median usability ratings of 4 to 5 (IQRs 0-1) out of 5, indicating strong usability across a diverse sample. The ORCA-PD score significantly correlated with the Montreal Cognitive Assessment score (ρ=0.45, 95% CI 0.21-0.64; P<.001; n=56), supporting convergent validity. The ORCA-PD scores also followed expected significant trends: neurotypical controls scored higher than participants with PD (β=4.18; P=.048) and participants with PD without mild cognitive impairment scored higher than participants with PD with mild cognitive impairment (β=7.22; P=.046), confirming 2 discriminative abilities.
CONCLUSIONS: ORCA-PD demonstrated usability and preliminary validity. ORCA-PD offers an accessible, scalable, and PD-sensitive cognitive screening test that could complement traditional in-person, supervised tools.
OBJECTIVE: The goal of this study was to address these challenges by leveraging the internet. This study aimed to develop a sensitive tool to detect cognitive impairments in early- to mid-stage PD in an accessible and scalable manner.
METHODS: We developed the Online Rapid Cognitive Assessment for Parkinson's Disease (ORCA-PD), a brief (~15 min), fully self-administered tool, tailored to detect PD-specific impairments remotely. In a cross-sectional study, 112 participants from diverse geographical locations completed the ORCA-PD and a usability questionnaire. Task selection for ORCA-PD was guided by meta-analyses and comprehensive reviews, which demonstrated medium-to-high sensitivity to PD compared to healthy controls.
RESULTS: Participants from more than 30 geographical locations showed a 93% (135/145) completion rate, with median usability ratings of 4 to 5 (IQRs 0-1) out of 5, indicating strong usability across a diverse sample. The ORCA-PD score significantly correlated with the Montreal Cognitive Assessment score (ρ=0.45, 95% CI 0.21-0.64; P<.001; n=56), supporting convergent validity. The ORCA-PD scores also followed expected significant trends: neurotypical controls scored higher than participants with PD (β=4.18; P=.048) and participants with PD without mild cognitive impairment scored higher than participants with PD with mild cognitive impairment (β=7.22; P=.046), confirming 2 discriminative abilities.
CONCLUSIONS: ORCA-PD demonstrated usability and preliminary validity. ORCA-PD offers an accessible, scalable, and PD-sensitive cognitive screening test that could complement traditional in-person, supervised tools.